Loading...
Expression of Survivin Does Not Appear to Influence Breast Cancer Recurrence Risk
BACKGROUND: Survivin is an inhibitor of apoptosis, and its expression associates with poor outcomes in multiple cancers. It may be a therapeutic target due to its unique expression in cancer cells. METHODS: We estimated the association between nuclear and cytoplasmic survivin expression in primary t...
Na minha lista:
| Udgivet i: | Acta Oncol |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6386593/ https://ncbi.nlm.nih.gov/pubmed/30351173 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/0284186X.2018.1503419 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|